Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity

Amyloid beta (Abeta) 1–42 oligomers accumulate in brains of patients with Mild Cognitive Impairment (MCI) and disrupt synaptic plasticity processes that underlie memory formation. Synaptic binding of Abeta oligomers to several putative receptor proteins is reported to inhibit long-term potentiation,...

Descripción completa

Detalles Bibliográficos
Autores principales: Izzo, Nicholas J., Xu, Jinbin, Zeng, Chenbo, Kirk, Molly J., Mozzoni, Kelsie, Silky, Colleen, Rehak, Courtney, Yurko, Raymond, Look, Gary, Rishton, Gilbert, Safferstein, Hank, Cruchaga, Carlos, Goate, Alison, Cahill, Michael A., Arancio, Ottavio, Mach, Robert H., Craven, Rolf, Head, Elizabeth, LeVine, Harry, Spires-Jones, Tara L., Catalano, Susan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229119/
https://www.ncbi.nlm.nih.gov/pubmed/25390692
http://dx.doi.org/10.1371/journal.pone.0111899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229119/
https://www.ncbi.nlm.nih.gov/pubmed/25390692
http://dx.doi.org/10.1371/journal.pone.0111899

Ejemplares similares